About this file

36C25619Q0819 P03 - SingleSourceJustification_MPT-SAT Vela Rgts 629.19.2.106.0398.pdf

View the file

Other files

File Type Posted
36C25619Q0819-004.pdf PDF
36C25619Q0819-003.docx DOCX document
36C25619Q0819-001.pdf PDF
36C25619Q0819-000.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

VHAPM Part 813.106 Simplified Acquisition Procedures: Soliciting from a Single Source Attachment 1: Single Source Justification for SAP under the SAT

VHAPM Part 813.106 Page 1 of 1 Original Date: 08/30/17 Revision 01 Eff Date: 04/23/2018

DEPARTMENT OF VETERANS AFFAIRS

Justification for Single Source Awards IAW FAR 13.106-1 For

Over Micro-Purchase Threshold but Not Exceeding the SAT ($250K)

Acquisition Plan Action ID: 36C25619AP2308

1. Contracting Activity: Department of Veterans Affairs, NCO 16, Division II, Supply Team C SHR for

VISN 16, Southeast Louisiana Veterans Healthcare System Medical Center, Department of Pathology and Laboratory Medicine Services, Molecular Pathology Laboratory

2237# 629-19-2-106-0398

2. Brief Description of Supplies/ Services required and the intended use/Estimated Amount:

To acquire Vela Sentosa Next Generation Sequencing (NGS) reagents and consumables for use on the Vela Sentosa NGS System to perform HCV resistance and HIV Genotype testing for the National Referral Lab Initiative. The estimated amount for the base year and additional per year for 3 option years grand total is under the SAT.

3. Unique characteristics that limit availability to only one source, with the reason no other supplies or services can be used:

Reagents are unique and proprietary for use on the Vela Sentosa Platform. This platform is being provided with full technical support and service by Vela Diagnostics. Samples are tracked throughout the entire procedure and the instruments will be interfaced for direct reporting of results. In addition, Vela Diagnostics is the only company which can provide reagents/tests in kit format for the entire process of sample extraction through result reporting. The Genotyping and Resistance testing methods are proprietary to Vela Diagnostics and are highly specialized and unavailable from other sources.

4. Description of market research conducted and results or statement why it was not conducted:

Performed an informal questionnaire, informal quotes, Internet searches to vendor websites, product catalogues and GSA Advantage government websites used for Market Research.

5. Contracting Officer's Certification: Purchase is approved in accordance with FAR13.106-1(b). I certify that the foregoing justification is accurate and complete to the best of my knowledge and belief.

____________________________ 5-7-2019 Title Date https://www.acquisition.gov/?q=/browse/far/13 https://acquisition.gov/far/current/html/Subpart%2013_1.html#wp1125466

2019-05-07T15:21:33-0500
Paul G Filhiol 664375

File details come from the government source that posted it.